表紙
市場調查報告書
商品編碼
1084387

酵素免疫分析法 (ELISA) 的世界市場趨勢、預測 (2022年∼2028年)

Enzyme Linked Immunosorbent Assay (ELISA) Market - Global Industry Insights, and Forecast, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

酵素免疫分析法 (ELISA) 的市場,主要由於感染疾病,媒介性疾病,癌症等慢性疾病的發生率增加而擴大。還有成本效益高的診斷工具的需求高漲,尤其是在低、中所得國中,也成為助長ELISA市場成長的要素之一。各手法中,由於高感度彈性高,成本績效出色,許多檢測套組廠商採用間接ELISA,獲得高市場佔有率。

本報告提供全球酵素免疫分析法 (ELISA) 的市場調查,市場定義和概要,市場成長的各種影響因素分析,市場規模的變化、預測,各種區分、各地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

第3章 市場動態、法律規章、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 產品銷售
  • M&A
  • 市場趨勢
  • 波特的五力分析
  • 疾病診斷的替代的免疫測量
  • 流行病學

第4章 全球酵素免疫分析法 (ELISA) 市場:各手法

  • 直接ELISA
  • 間接ELISA
  • 三明治ELISA
  • 競爭ELISA

第5章 全球酵素免疫分析法 (ELISA) 市場:各用途

  • 疫苗開發
  • 免疫
  • 診斷
  • 毒物
  • 醫藥品開發、製藥
  • 移植

第6章 全球酵素免疫分析法 (ELISA) 市場:各技術

  • 化學冷光
  • 比色
  • 螢光

第7章 全球酵素免疫分析法 (ELISA) 市場:各地區

  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
  • 企業簡介
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • ALPCO
    • BioLegand, Inc.
    • Biomerieux SA
    • Enzo Life Sciences, Inc.
    • Zeus Scientific, Inc.
    • Shenzhen YHLO Biotech Co. Ltd.

第9章 Section

第10章 Section

目錄
Product Code: CMI1505

Enzyme Linked Immunosorbent Assay (ELISA) is one of the promising techniques used for the detection and quantification of biological analytes such as peptides, proteins, antibodies, and hormones. This technique can be useful to provide a quick and cost-effective assay to measure the concentration of unknown antigen or antibody in a specific analyte. ELISA finds its extensive application as a diagnostic tool in medicines as well as to monitor and quality check-up procedures in drug development processes at various industries. ELISA can be performed by different type of methods that include direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA. The high sensitivity, flexibility and cost effectiveness of indirect ELISA makes it an ideal choice of most of the test kit manufacturers and thus possess the highest market share.

Market Dynamics

The Enzyme Linked Immunosorbent Assay (ELISA) Market is expanding owing to the increasing incidence of chronic diseases mainly in case of infectious diseases, vector borne diseases and cancer. According to the National Cancer Institute, cancer has a major impact on the population of U.S. and across the world. The NCI reports approximately 1,685,210 new cases of cancer were diagnosed in 2016. Also, reports demand for efficient detection tests that can be sufficed with the help of ELISA test kits. Moreover, increasing demand for cost-effective diagnostic tool is one of the factor aiding the growth of ELISA market, especially in the low and middle income economies. For instance, in October 2021, the Nigerian government and World Health Organization (WHO) launched a campaign to vaccinate around 874,000 people against yellow fever in two states of the country Kwara and Kogi in alliance with the International Coordination Group. The samples of the patients suspected with yellow fever were further tested with the help of ELISA test at the Pasteur Institute in Dakar. However, availability of alternate immunoassays and cross reactivity projected by these tests can hinder the market growth. Development of cost-effective ELISA tests with improved reliability and accuracy can provide potential opportunity for market players to strategize their growth in the global ELISA market.

Key features of the study:

This report provides in-depth analysis of Enzyme Linked Immunosorbent Assay (ELISA) Market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global Enzyme Linked Immunosorbent Assay (ELISA) Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study includes Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global Enzyme Linked Immunosorbent Assay (ELISA) Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Enzyme Linked Immunosorbent Assay (ELISA) Market

Detailed Segmentation:

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology:

Chemiluminescent

Colorimetric

Fluorescent

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Geography:

By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

By Technology:

Chemiluminescent

Colorimetric

Fluorescent

By Country:

U.S.

Canada

North America

Latin America

By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

By Technology:

Chemiluminescent

Colorimetric

Fluorescent

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

 Europe

By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

By Technology:

Chemiluminescent

Colorimetric

Fluorescent

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

By Technology:

Chemiluminescent

Colorimetric

Fluorescent

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

By Technology:

Chemiluminescent

Colorimetric

Fluorescent

By Country:

GCC

Israel

Rest of Middle East

Africa

By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

By Technology:

Chemiluminescent

Colorimetric

Fluorescent

By Country:

South Africa

Central Africa

North Africa

Company Profiles

Bio-Rad Laboratories, Inc. *

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Market Strategies

Thermo Fisher Ssienctific, Inc.

ALPCO

BioLegand, Inc.

Biomerieux S.A.

Enzo Life Sciences, Inc.

Zeus Scientific, Inc.

Shenzen YHLO Biotech Co. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Method
    • Market Snippet, By Application
    • Market Snippet, By Technology
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Product Launches
  • Mergers and Acquisitions
  • Market Trends
  • Porter's Five Forces Analysis
  • Alternative Immunoassays for Disease Diagnostics
  • Epidemiology

4. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Direct ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Indirect ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Sandwich ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Competitive ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Vaccine Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Toxicology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Drug Development & Pharmaceutical Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Chemiluminescent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Colorimetric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Fluorescent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Region, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Region, 2017 - 2028
  • North America
    • Market Size and Forecast, By Method, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Technology, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Method, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Technology, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Method, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Technology, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Method, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Technology, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Method, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Technology, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Method, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Technology, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • ALPCO
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • BioLegand, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Biomerieux S.A.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Enzo Life Sciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Zeus Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Shenzhen YHLO Biotech Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies

9. Section

  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact